Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts.

Purohit T, Qin Z, Quan C, Lin Z, Quan T.

PLoS One. 2017 Mar 7;12(3):e0173191. doi: 10.1371/journal.pone.0173191. eCollection 2017.

2.

Renal Fibrosis mRNA Classifier: Validation in Experimental Lithium-Induced Interstitial Fibrosis in the Rat Kidney.

Marti HP, Jeffs A, Scherer A, Leader J, Leader C, Bedford J, Walker R.

PLoS One. 2016 Dec 21;11(12):e0168240. doi: 10.1371/journal.pone.0168240. eCollection 2016.

3.

CCN family of proteins: critical modulators of the tumor cell microenvironment.

Yeger H, Perbal B.

J Cell Commun Signal. 2016 Sep;10(3):229-240. Epub 2016 Aug 12.

4.

Matricellular protein CCN3 mitigates abdominal aortic aneurysm.

Zhang C, van der Voort D, Shi H, Zhang R, Qing Y, Hiraoka S, Takemoto M, Yokote K, Moxon JV, Norman P, Rittié L, Kuivaniemi H, Atkins GB, Gerson SL, Shi GP, Golledge J, Dong N, Perbal B, Prosdocimo DA, Lin Z.

J Clin Invest. 2016 Apr 1;126(4):1282-99. doi: 10.1172/JCI82337. Epub 2016 Mar 14.

5.

Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Sawyer AJ, Kyriakides TR.

Adv Drug Deliv Rev. 2016 Feb 1;97:56-68. doi: 10.1016/j.addr.2015.12.016. Epub 2016 Jan 4. Review.

6.

The roles of connective tissue growth factor in the development of anastomotic esophageal strictures.

Zhao H, Zhao L, Zhou Z, Wu Y.

Arch Med Sci. 2015 Aug 12;11(4):770-8. doi: 10.5114/aoms.2015.48147. Epub 2015 Jan 8.

7.

New Insights for Oxidative Stress and Diabetes Mellitus.

Maiese K.

Oxid Med Cell Longev. 2015;2015:875961. doi: 10.1155/2015/875961. Epub 2015 May 12. Review.

8.

Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.

Wang M, Liu Y, Zou J, Yang R, Xuan F, Wang Y, Gao N, Cui H.

Oncotarget. 2015 Apr 20;6(11):9517-30.

9.
10.

Expression of connective tissue growth factor in male breast cancer: clinicopathologic correlations and prognostic value.

Lacle MM, van Diest PJ, Goldschmeding R, van der Wall E, Nguyen TQ.

PLoS One. 2015 Mar 4;10(3):e0118957. doi: 10.1371/journal.pone.0118957. eCollection 2015.

11.
12.

Revisiting the matricellular concept.

Murphy-Ullrich JE, Sage EH.

Matrix Biol. 2014 Jul;37:1-14. doi: 10.1016/j.matbio.2014.07.005. Epub 2014 Jul 24. Review.

13.

Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.

Planck T, Shahida B, Sjögren M, Groop L, Hallengren B, Lantz M.

Thyroid. 2014 Jul;24(7):1156-61. doi: 10.1089/thy.2013.0654. Epub 2014 Jun 3.

14.

Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice.

Liu J, Ren Y, Kang L, Zhang L.

PLoS One. 2014 Apr 10;9(4):e94912. doi: 10.1371/journal.pone.0094912. eCollection 2014.

15.

Gene expression alterations in the cerebellum and granule neurons of Cstb(-/-) mouse are associated with early synaptic changes and inflammation.

Joensuu T, Tegelberg S, Reinmaa E, Segerstråle M, Hakala P, Pehkonen H, Korpi ER, Tyynelä J, Taira T, Hovatta I, Kopra O, Lehesjoki AE.

PLoS One. 2014 Feb 27;9(2):e89321. doi: 10.1371/journal.pone.0089321. eCollection 2014.

16.

The CCN family proteins: modulators of bone development and novel targets in bone-associated tumors.

Chen PC, Cheng HC, Yang SF, Lin CW, Tang CH.

Biomed Res Int. 2014;2014:437096. doi: 10.1155/2014/437096. Epub 2014 Jan 14. Review.

17.

CCN3 protein participates in bone regeneration as an inhibitory factor.

Matsushita Y, Sakamoto K, Tamamura Y, Shibata Y, Minamizato T, Kihara T, Ito M, Katsube K, Hiraoka S, Koseki H, Harada K, Yamaguchi A.

J Biol Chem. 2013 Jul 5;288(27):19973-85. doi: 10.1074/jbc.M113.454652. Epub 2013 May 7.

18.

CCN proteins: A centralized communication network.

Perbal B.

J Cell Commun Signal. 2013 Aug;7(3):169-77. doi: 10.1007/s12079-013-0193-7. Epub 2013 Feb 19.

19.
20.

Supplemental Content

Support Center